Affiliations
AffiliationsItem in Clipboard
Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA TestingGregory S Cooper et al. J Am Board Fam Med. 2021 Jan-Feb.
Free article . 2021 Jan-Feb;34(1):61-69. doi: 10.3122/jabfm.2021.01.200345. AffiliationsItem in Clipboard
AbstractBackground: Fecal immunochemical testing (FIT) and multi-target stool DNA testing (mt-sDNA) are recommended colorectal cancer screening options but require follow-up with colonoscopy to determine the source of a positive result. We performed a retrospective analysis in an academic health system to determine adherence to colonoscopy in these patients.
Methods: We identified all patients aged 40 years and older with at least 1 primary care visit who had a positive FIT or mt-sDNA between January 2016 and June 2018. We identified receipt of colonoscopy within 6 months of the positive test and reviewed medical records to determine reasons for lack of colonoscopy.
Results: We identified 308 eligible patients with positive FIT and 323 with positive mt-sDNA. Some patients with positive FIT (46.7%) and patients with positive mt-sDNA (71.5%) underwent colonoscopy within 6 months, and time to colonoscopy was also shorter with mt-sDNA (hazard ratio, 1.83; 95% CI, 1.48-2.25). These differences remained in a multivariable model adjusting for patient characteristics. Among patients without colonoscopy after positive FIT, 1 or more system, provider, and patient-related barriers were identified in 32.1%, 57.6%, and 36.3%, respectively. Among patients without colonoscopy after positive mt-sDNA, corresponding frequencies were 30.4%, 43.5%, and 57.6%, respectively.
Conclusions: Follow-up colonoscopy was higher for mt-sDNA than FIT, which could be due in part to preselection by clinicians and/or patients. Among patients who did not follow-up, provider and system factors were as frequently encountered as patient factors. These findings reinforce the need for multi-level interventions to improve follow-up.
Keywords: Cancer Screening; Colonoscopy; Colorectal Cancer; Mass Screening; Occult Blood.
© Copyright 2021 by the American Board of Family Medicine.
Conflict of interest statementConflict of interest: None.
Similar articlesFendrick AM, Fisher DA, Saoud L, Ozbay AB, Karlitz JJ, Limburg PJ. Fendrick AM, et al. Cancer Prev Res (Phila). 2021 Sep;14(9):845-850. doi: 10.1158/1940-6207.CAPR-21-0075. Epub 2021 May 21. Cancer Prev Res (Phila). 2021. PMID: 34021023 Free PMC article.
Engel-Nitz NM, Miller-Wilson LA, Le L, Fisher DA. Engel-Nitz NM, et al. Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(7):843-852. doi: 10.1080/14737167.2023.2220965. Epub 2023 Jul 18. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37462667
Redwood DG, Dinh TA, Kisiel JB, Borah BJ, Moriarty JP, Provost EM, Sacco FD, Tiesinga JJ, Ahlquist DA. Redwood DG, et al. Mayo Clin Proc. 2021 May;96(5):1203-1217. doi: 10.1016/j.mayocp.2020.07.035. Epub 2021 Apr 9. Mayo Clin Proc. 2021. PMID: 33840520
Narayani KR, Narayani RI. Narayani KR, et al. J Clin Gastroenterol. 2024 May-Jun 01;58(5):471-474. doi: 10.1097/MCG.0000000000001884. Epub 2023 Jun 27. J Clin Gastroenterol. 2024. PMID: 37389965 Review.
Zou J, Xiao Z, Wu Y, Yang J, Cui N. Zou J, et al. Clin Chim Acta. 2022 Jan 1;524:123-131. doi: 10.1016/j.cca.2021.10.030. Epub 2021 Oct 28. Clin Chim Acta. 2022. PMID: 34756863 Review.
Fendrick AM, Lieberman D, Vahdat V, Chen JV, Ozbay AB, Limburg PJ. Fendrick AM, et al. Cancer Prev Res (Phila). 2022 Oct 4;15(10):653-660. doi: 10.1158/1940-6207.CAPR-22-0153. Cancer Prev Res (Phila). 2022. PMID: 35768200 Free PMC article.
Subramanian S, Tangka FKL, Hoover S, Mathews A, Redwood D, Smayda L, Ruiz E, Silva R, Brenton V, McElroy JA, Lusk B, Eason S. Subramanian S, et al. Cancer Causes Control. 2024 Nov;35(11):1467-1476. doi: 10.1007/s10552-024-01898-w. Epub 2024 Aug 6. Cancer Causes Control. 2024. PMID: 39107449 Free PMC article.
Hu YT, Chen XF, Zhai CB, Yu XT, Liu G, Xiong ZG, Wang ZQ, Cai SJ, Li WC, Kong XX, Xiao Q, Wang CH, Tao ZH, Niu LY, Men JL, Wang Q, Wei SZ, Hu JJ, Yang TH, Peng JJ, Jiang GZ, Lv N, Chen YY, Zheng S, Gu YH, Ding KF. Hu YT, et al. MedComm (2020). 2023 Aug 12;4(4):e345. doi: 10.1002/mco2.345. eCollection 2023 Aug. MedComm (2020). 2023. PMID: 37576863 Free PMC article.
Karlitz JJ, Fendrick AM, Bhatt J, Coronado GD, Jeyakumar S, Smith NJ, Plescia M, Brooks D, Limburg P, Lieberman D. Karlitz JJ, et al. Popul Health Manag. 2022 Jun;25(3):343-351. doi: 10.1089/pop.2021.0185. Epub 2021 Dec 24. Popul Health Manag. 2022. PMID: 34958279 Free PMC article.
Dolatkhah R, Somi MH, Dastgiri S, Asghari Jafarabadi M, Mashhadi Abdolahi H, Shanehbandi D, Asadi M, Nezamdoust M, Dolatkhah N, Farassati F. Dolatkhah R, et al. Ann Med Surg (Lond). 2022 Mar 12;76:103494. doi: 10.1016/j.amsu.2022.103494. eCollection 2022 Apr. Ann Med Surg (Lond). 2022. PMID: 35345791 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3